RÉSUMÉ CONTEXTE: En dépit du volume de connaissances, une surveillance accrue et le contrôle des infections mesures adoptées par les établissements de soins de santé pour traiter le caractère endémique et d'épidémies fréquentes de la méticilline-resistant Staphylococcus aureus (MRSA) dans les hôpitaux et les établissements de soins de santé les infections, dans le monde entier en raison de cet organisme sont encore responsable d'environ 50% des infections nosocomiales à S. aureus, avec des taux croissants de morbidité et de mortalité. OBJECTIF: fournir aux cliniciens des informations régionales actuelles sur l'épidémiologie moléculaire, la détection en laboratoire et les aspects cliniques de SARM. MÉTHODES: Une revue des littératures publié le SARM dans les bibliothèques médicales et des citations bibliographiques sur PubMed, Medline et d'Afrique Index Medicus sur l'épidémiologie moléculaire et clinique des maladies causées par le SARM et l'évaluation du laboratoire des dernières approches diagnostiques.

RÉSULTATS: Cet examen a montré qu'il ya eu propagation intercontinentale de certains clones hautement pathogène du SARM menaçant de créer des risques de santé publique de proportion sans précédent, avec le plus grand défi pour l'humanité, étant le développement de la résistance à plusieurs antibiotiques, qui ces derniers temps, avait inclus résistance à la vancomycine et les glycopeptides autres, le seul groupe antibiotique efficace contre elle. Ajouté à cette charge est l'émergence de souches plus virulentes de SARM-AC (CA-MRSA) qui, au tournant du siècle, a été signalé de plus en plus de provoquer des infections et des épidémies dans les populations sans facteurs de risque prédisposants, avec des taux élevés de morbidité et de préposé la mortalité. CONCLUSION: Il est nécessaire pour la surveillance active de SARM par les établissements de soins de santé en Afrique afin d'identifier les foyers potentiels, et de vigilance dans l'application des mesures de contrôle des infections telles que la prescription rationnelle des antibiotiques, lavage des mains, la désinfection et la stérilisation qui peut limiter l'émergence et la propagation des plus résistants clones de SARM. WAJM 2009; 28 (5): 281-290.
INTRODUCTION
Staphylococcus aureus is a nonmotile, aerobic or facultatively anaerobic Gram positive coccus that inhabits the nasal membranes and skin of warm blooded animals, in whom it causes a range of infections from mild, such as skin infections and food poisoning, to lifethreatening, such as pneumonia, sepsis, osteomyelitis and infectious endocarditis. 1 In the pre-antibiotic era, the rate of mortality from invasive S. aureus disease was high and the introduction of penicillin into the market had a dramatic impact on treatment. Shortly after the introduction of penicillin and its widespread use as a chemotherapeutic agent, strains of S. aureus resistant to penicillin through the production of β-lactamase (penicillinase), an enzyme that destroy the β-lactam ring of penicillin, emerged. Methicillin, a semisynthetic penicillin, was introduced in 1959 to overcome the problems that arose from the increasing prevalence of penicillinase-producing strains of S. aureus. Within a very short time, strains of S. aureus resistant to methicillin rapidly emerged 2 and became a major clinical problem within hospitals in Europe in the 1960s 3 and in the United States in the 1970s 4 and since then in several countries of the world. 5 Resistance to methicillin is conferred on S. aureus by the acquisition of a mecA gene 6 which has recently been localized within a large (52-kb) DNA cassette designated staphylococcus cassette chromosome mec (SCCmec) inserted in the bacterial chromosome. 7 The mecA gene encodes a β-lactam insensitive cell wall synthesis enzyme called penicillin binding protein 2a or 2' (PBP 2a or PBP 2'), a 78 kD protein with low affinity for β-lactam agents. 8 The SCCmec is known to contain additional genes conferring resistance to aminoglycosides, bleomycin and macrolide-lincosamide-streptograninB (MLS B ) groups of antibiotic. 9 Acquisition of SCCmec therefore provides S. aureus with array of resistance genes that make it the most resistant pathogenic organism in hospital acquired infections.
World wide, MRSA now comprise up to 50% of S. aureus isolates in hospitals 10 , and is involved in surgical wound infections, nosocomial pneumonias, bacteraemias and other forms of infections . Treatment options  have been severely restricted to  potentially toxic antimicrobials such as  vancomycin and other glycopeptides,   11 leading to increasing mortality, morbidity and costs. 10 In the 1980s, MRSA emerged as a community-acquired pathogen causing infections in people without identifiable established risks. 12 These community-acquired MRSA infections, which were first noticed among intravenous drug addicts, have in recent times become increasingly being reported among infants and children, 13 and among individuals involved in intense contact sports 14 with attendant morbidity and considerable mortality.
Over the years, there has been improvement in diagnostic methodology of MRSA, particularly the phenotypic detection of hetero-resistant strains, using conventional antimicrobial susceptibility testing such as the methicillin/oxacillin disk diffusion, cefoxitin disk diffusion, broth microdilution, oxacillin agar screen, population profile analysis, oxacillin and cefoxitin E-test and many automated methods. 15, 16 Molecular detection of mecA gene using DNA probe or its products PBP 2' by immunoblot assay and PCR based methods are now considered the 'gold' standard for MRSA confirmation. 17 Epidemiological typing methods to characterize MRSA strains involved in outbreaks have also moved from the use of bacteriophage typing, protein antigen electrophoresis profile and plasmid fingerprinting to pulse field gel electrophoresis (PFGE) of SmaI-digest of genomic DNA, ribotyping, multilocus sequence typing (MLST), PCR amplification of target genes such as staphylococcus protein A (spa) and coagulase (coa) genes, and more recently sequencing of these DNA. 18 From published literatures available, MRSA reporting in Nigeria and other parts of Africa appear very few. Does this imply that MRSA occurence is low in Africa, and the continent is therefore not at risk of the global threat posed by MRSA? This review is intended to provide clinicians, most especially those in developing countries of Africa, up-todate information on the molecular epidemiology, clinical significance and laboratory detection methods of MRSA, and the need for increased surveillance of infectious diseases especially those caused by MRSA.
EPIDEMIOLOGY OF MRSA
Historical perspectives
The strain of Staphylococcus aureus resistant to methicillin was first detected in England in 1960 2 following the introduction of methicillin (the prototypal penicillinase resistant penicillin) in 1959. These strains were encountered steadily across the UK and Europe during the decade but their clinical significance was overlooked. By the late 1960s however, an unusual increase in the frequency of clinically significant isolates in Britain occurred 3 and by the turn of that decade, they had become recognized as nosocomial pathogens in the UK and across Europe. During this period, few sporadic cases and epidemic outbreaks of MRSA were reported in the United States but by 1975, nosocomial MRSA infections in United States hospitals were widely reported. 4 In the 1980s, MRSA infections were reported in persons who had no previous hospitalization. 12 These infections appeared to be acquired in the community and were termed community-acquired MRSA (CA-MRSA) infections. Both healthcare-associated MRSA (HA-MRSA) and CA-MRSA infections have since been reported worldwide. 25 started noting an increasing trend in the number of CA-MRSA infections seen in young, healthy populations without predisposing risk factors. CA-MRSA infections have so far been reported among infants and children 13 and outbreaks have been reported among individual involved in intense contact sports such as rugby, wrestling, football and soccer.
14, 26
Epidemiology of MRSA in Nigeria
Although strain of Staphylococcus aureus resistant to methicillin was first detected in England in 1960 2 , it was not until 1987 that Rotimi et al 27 gave the first documentation of MRSA in Nigeria; 50.6% (42 of 83) of S. aureus the In Nigeria, there are no systematic ways of reporting infectious diseases. Most health institutions lack proper infection control programmes and there are no coordination of efforts among public health authorities. There is hence no national policy for screening, reporting and control of MRSA outbreaks. Only few institutions, as reported above, carry out limited survey of MRSA, which is usually not sustained because of lack of institutional support (personal communication).
All but one of the institutions used disk diffusion test on Mueller-Hinton agar with 5µg methicillin or 1µg oxacillin to screen for methicillin resistance. Although methicillin 5µg, nafcillin 1ìg and oxacillin 1µg disks have been successfully used to screen for methicillin resistance in S. aureus, oxacillin probably gives the best standardized and reliable result for disk diffusion test because of its stability. Because standard inoculum disk diffusion test with oxacillin 1ìg disk may not detect some hetero-resistant strains of MRSA, the tendency is underreporting of the true prevalence of MRSA from these surveys. Adding to this problem is the fact that there is no reference laboratory in Nigeria where MRSA isolated through screening/ surveillance can be confirmed genetically and assigned to clonal group. The implication is that MRSA infections/ outbreaks in Nigeria are largely undetected and their contributions to mortality, morbidity and cost of care, associated with hospital-acquired infections are unknown.
Molecular Basis of Methicillin Resistance in Staphylococcus Aureus
As 32 This gene was found to be widely distributed among S. aureus as well as coagulase negative staphylococci. It was hence speculated that the mec determinant must be freely transmissible among staphylococcal species. However, with a detailed epidemiological study, Kreiswirth et al 33 proposed that MRSA originated from a single or two ancestral clones. This led to the view that the frequency of inter or intra species transmission of mec A is a rather limited process and that mec transmission may not be due to specialized transmission machinery such as a transposon.
In 1999, mecA gene of S. aureus strain N315 (MRSA isolated in 1982 from pharyngeal smear of a Japanese patient) was shown to be localized within a large (52-kb) DNA cassette designated staphylococcus cassette chromosome mec (SCCmec) inserted in the chromosome. By sequence determination of the entire DNA of the SCCmec, 7 two novel genes designated staphylococcal cassette chromosome recombinase genes (ccrA and ccrB) encoding polypeptides, CcrA (449 amino acids) and CcrB (542 amino acids) having partial homology to recombinases of the invertase/resolvase family were described. These recombinases were found to catalyze precise excision of SCCmec from MRSA chromosome and its site/sequencespecific integration into S. aureus chromosomes when introduced into cells as a recombinant multicopy plasmid.
The whole genome sequencing of MRSA N315 strain and another related strain, Mu50 (an MRSA strain with vancomycin intermediate resistance, VISA, isolated in 1997 from the pus of a Japanese male baby with a surgical wound infection that did not respond to vancomycin), were done in 2001. 9 The resistance island SCCmec was found to contain in addition to mecA and ccr genes, additional genes encoding resistance to other antibiotics making S. aureus the most resistant pathogenic organism in hospital acquired infections. Using conventional and multiplex PCR, four structural types of SCCmec, designated type I-IV, were initially described but because the SCCmec chromosomal regions were found to be highly recombinogenic which results in a variety of SCCmec types, Chongtrakool et al 34 have suggested a new proposal for the nomenclature for SCCmec.
Clinical Significance of MRSA
Mortality from invasive disease from both HA-and CA-MRSA infections is high. Recent meta analysis by Cosgrove et al 35 showed higher mortality in patients with MRSA bacteramia when compared to MSSA bacteraemia. This was partly due to the fact that patients with MRSA infections had more comorbidities and were generally older than those with MSSA bacteraemia. In another study by Perovic et al, 36 33 .3% of 105 patients with MRSA bacteraemia died within 14 days of admission, compared to 20.1% of 344 patients with MSSA bacteraemia (p = 0.0048). Oxacillin, ofloxacin and rifampicin resistance, and admission into intensive care units were highly significant predictors of mortality in the study.
Because of the multi-resistant nature of MRSA, the choice of antibiotic treatment of MRSA infection is limited to few but potentially toxic drugs such as vancomycin. 11 The emergence of MRSA strains with reduced vancomycin susceptibility and vancomycin resistance has further complicated therapy of MRSA infections as only few investigational drugs are currently on trial.
MRSA infection takes longer time to treat and prolongation of infection encourages nosocomial transmission of pathogen and disease oubreaks in hospitals. Prolonged hospital stay increase cost of treatment to individual, hospital and the government. Extensive eradication procedures needed to ensure that colonized or infected patients are completely free of the pathogen is very costly. 37 There is also loss of 'manhour' at work leading to decrease productivity.
MRSA has capacity to acquire, in addition to multi-resistant genes, other genes that encode toxin production such as Panton-Valentine leukocidin (PVL), which causes pore formation on On the other hand, methods to enhance sensitivity in detection of methicillin resistance, such as increase salt concentration of media and prologed (48hours) incubation, can lead to erroneous categorization of susceptible strains as resistant. Genotypic detection of mecA gene or its product, PBP 2' (PBP2a) by immunoblot assay, is however now considered the 'gold standard' for MRSA confirmation.
Phenotypic Methods of Detecting Methicillin Resistance
The methods for detection of methicillin resistance most commonly used in the clinical laboratories and for which sufficient data are available to judge their reliability are the disk diffusion, broth dilution, agar screen, Etest and many of the several automated systems. i.
Disk diffusion susceptibility testing. This method, which has been proven reliable in detecting methicillin resistance, can be performed using 1µg oxacillin disk, 1 µg nafcillin disk, 5µg methicillin disk and very recently 10µg or 30µg cefoxitin disk. 
Genotypic method of detecting methicillin resistance
The 'gold standard' for MRSA detection/confirmation is one of the several genotypic methods for detecting the mecA gene that encodes the abnormal penicillin binding protein 2' (PBP 2') responsible for methicillin resistance. In the clinical laboratory, mecA gene can be detected using the three hours DNA hybridization probe. 17 This is highly sensitive and specific and correlates with phenotypic susceptibility testing and other genotyping methods. However, the polymerase chain reaction (PCR) is now the most frequently used genotypic 
Table3: Comparison of different methods for detecting methicillin resistance in Staphylococcus aureus
Method
Recent Epidemiological Typing Methods of MRSA
It is sometimes desirable to separate strains of S. aureus into types or groups because of the ubiquitous nature of the organism. This is usually indicated to detect outbreak of S. aureus infections in hospitals as well as in the community. For good understanding of the population and evolutionary biology of S. aureus (MRSA and MSSA), and to determine the origin, spread and relatedness of MRSA (or MSSA) clones described by different laboratories, isolates of this species need to be characterized unambiguously. Typing methods should have high and relevant discriminatory power and typeability, good reproducibility, applicability to all organisms of interest, ease of use, produce data that can be easily transferred between laboratories or presented in published work and be cost effective. 43 Many of the conventional epidemiological typing methods that have been used for MRSA such as serotyping, biotyping, antibiotic susceptibility profiling (antibiogram), surface protein electrophoresis, multilocus enzyme electrophoresis and bacteriophage typing, do not meet many of these criteria. These typing methods are no longer in use with the exception of bacteriophage and zymotyping, which are still being used by some large reference laboratories around the world for typing S. aureus, and serotyping, which has been limited to epidemiological surveillance of Salmonella species.
In recent times therefore, typing methods for study of local and global epidemiologies of MRSA have shifted from these conventional techniques to molecular methods, which offer advantages in typeability, discrimination and reproducibility. Molecular typing methods used to characterize MRSA strains include plasmid fingerprinting, pulse field gel electrophoresis (PFGE) of SmaI digested genomic DNA, ribotyping and PCR-based amplification/sequencing of target genes such as repetitiveelement PCR, multilocus sequence typing (MLST), SCCmec typing and staphylococcal protein A (spa) typing. i.
Plasmid fingerprinting. This is a strong tool for bacterial strain identification and surveillance of nosocomial and community acquired infections. The diversity and stability of plasmids carried by MRSA strains during outbreaks, 44 the ease of plasmid detection by gel electrophoresis from crude bacterial lysate and the reproducibility of detection method made plasmid fingerprinting a powerful epidemiological typing tool for MRSA. In fingerprinting, plasmids are first extracted from lysed bacteria Interpretive criteria for bacterial strain typing using PFGE has been set by Tenover et al 46 and applied to non-outbreak situations to track the national and international dissemination of S. aureus clones. Multicenters studies using PFGE are now possible due to recent advances in the standardization of electrophoretic conditions. 47 The major demerits of PFGE are that it may be too discriminatory for other than local or short-term epidemiological analysis, the arbitrary nature of the interpretive criteria and occasional requirement for subjective analysis of complex band patterns. iii. Multilocus sequence typing (MLST). This is an investigatory tool in many studies of S. aureus evolution and epidemiology, and has had a large impact on the field of bacterial strain typing. 49 In this typing method, the short sequence repeat region of the spa gene is sequenced and the sequence obtained is compared to those found in the Internet accessible spa sequence database Spaserver (http://www.ridom.de/ spaserver/ vi. Combined typing approach. This is the approach recommended by the EU-funded Harmony project 50 for more widespread epidemiological typing of MRSA. In this approach, PFGE and/or spa typing is initially used to determine genetic relatedness of different isolates and MLST/SCCmec typing is then used 
What Needs to be Done in Nigeria
Although reports of MRSA colonization and infections from Nigeria and other African countries (except South Africa) are very few in the literature, this does not equate to low prevalence of this infection. Only few institutions carry out limited (unsustained) survey of MRSA and most clinicians are unaware of the attributable mortality or morbidity due to MRSA infection (personal communication). The clinical significance of MRSA is hence overlooked. Two studies from the same institutions 25, 26 in Nigeria have reported MRSA strains resistant to vancomycin without any history of exposure to vancomycin. The mechanism of resistance of these MRSA strains to vancomycin is not known as all cases of vancomycin resistance reported in literature so far are from patients who have been on prolonged vancomycin therapy. It will be interesting to know the mechanism of vancomycin resistance in what may appear to be an MRSA strain indigenous to Nigeria.
Because most strains of MRSA in Nigeria are still sensitive to the fluoroquinolones, 28, 36, 42, 46 there may be no percieve real danger of serious infections since several fluoroquinolones brand are available in the country. However, there is need for active surveillance of hospitalized patients and heath care personnel for MRSA by the clinical and laboratory departments to identify potential sources of outbreaks. All patients admitted into hospital must be screened for MRSA and new staff should be screened for MRSA carriage. There should be isolation and treatment of all colonized or infected staff and they must be prevented from handling patients until all organism have been eradicated from them. This is a measure that has been applied in Australia to control the spread of MRSA infections and outbreaks.
Clinical microbiology laboratories in Nigeria must begin to routinely screen all clinical samples received in the laboratory for MRSA and report to infection control unit of the institution, of any positive case; colonized or infected. In addition, there must be coordination of efforts among public health authorities about investigation and reporting of an outbreak in Nigerian hospitals. There is urgent need for a public health reference laboratory saddle with the responsibility of establishing a national MRSA database for Nigeria through systematic surveillance, identification and confirmation of all suspected MRSA isolates sent to it from various health care institutions and assignment into clonal groups.
There is also need for vigilance in the enforcement of infection control measures that can limit emergence of more resistant clones of MRSA and spread of infection in the hospital and community, such as rational prescription of antibiotic, handwashing, disinfection and sterilization.
